ReviewChest2021

Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration Workshop.

Patrick A Flume et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.